Home › Disorders of Excessive Somnolence › Ohio
Disorders of Excessive Somnolence clinical trials in Ohio
10 studies for Disorders of Excessive Somnolence are looking for participants at sites in Ohio.
Cities in Ohio
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Neuroscience Research Center, LLC, Canton
- Intrepid Research, Cincinnati
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07500090A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Cincinnati, Ohio, Cincinnati
- Dublin, Ohio, Dublin
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Sep 11, 2026 · NCT07598708A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Cincinnati
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07455383A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Alkermes Investigational Site, Cincinnati
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07502443A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
- Alkermes Investigational Site, Cincinnati
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07540897A Study of Pitolisant in Patients With Prader-Willi Syndrome
- Center for Human Genetics, Cleveland
RecruitingPhase 3
Ages 6 and older · All sexes · Updated Aug 25, 2026 · NCT06366464A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Canton
- Alkermes Investigational Site, Cincinnati
- Alkermes Investigational Site, Cincinnati
- and 1 more
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Aug 7, 2026 · NCT06767683Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
- Clinical Research Site, Cincinnati
- Clinical Research Site, Cincinnati
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 24, 2026 · NCT06568367Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Cincinnati
- Clinical Research Site, Cincinnati
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 24, 2026 · NCT07484217A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Cincinnati, Ohio, Cincinnati
- Dublin, Dublin
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Apr 16, 2026 · NCT07096674From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.